Latest news
Boron-Containing Drug Candidates in Clinical Trials - Springer Nature LinkSpringer Nature Link · Fri, 07 Aug 2026 05:08:09 GMTSpringer Nature raises outlook as research division drives first-half growth - The BooksellerThe Bookseller · Thu, 06 Aug 2026 07:52:12 GMTSpringer Nature and OpenEvidence Announce Agreement to Maximise Exposure of Trusted Findings On OpenEvidence Platform - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTSpringer Nature reports strong first-half growth - Research InformationResearch Information · Wed, 05 Aug 2026 07:34:44 GMTSpringer Nature content integrated into OpenEvidence under new agreement - Research InformationResearch Information · Wed, 05 Aug 2026 07:26:50 GMTSpringer Nature Expects FY26 Underlying Revenue Growth Around 6% - TradingViewTradingView · Wed, 05 Aug 2026 05:10:00 GMTDomperidone contraindicated in patients with phaeochromocytoma - Springer Nature LinkSpringer Nature Link · Sat, 01 Aug 2026 07:00:00 GMTSpringer Nature reports continued growth in TAs and OA publishing - Research InformationResearch Information · Fri, 31 Jul 2026 08:10:27 GMT